Note: The testimony presented here consists of witnesses' prepared statements and are not official transcripts of the proceedings.

 

Accutane - Is this Drug Treatment Linked to Depression and Suicide?

106 th Congress (1999-2000)

December 5, 2000
1:00 p.m.

Rayburn House Office Building

Chairman Burton's Opening Statement

WITNESS LIST

Panel I

The Family Perspective

Lori and Amanda Callais
Denham Springs, Louisiana

Stacy and Mike Baumann
Mundelein, Illinois

Charles H. Jackson, Jr.
Lubbock, Texas

Panel II

David M. Pariser, MD, FACP
American Academy of Dermatology
Pariser Dermatology Specialist, Ltd.
Virginia Clinical Research, Inc.
Norfolk, Virginia

Douglas Jacobs, MD
Roche Consultant
Associate Clinical Professor of
Psychiatry
Harvard Medical School
Wellesley, Massachusetts 

James T. O'Donnel, PharmD., M.S.
Assistant Professor of Pharmacology
Rush Medical School
Pallentine, Illinois

Dr. Jonca Bull
Food and Drug Administration
Accompanied by
Dr. Phyllis Huene



If you or someone you know has had complications after taking Accutane contact us for immediate evaluation of your situation.

Free Legal Consultation | Accutane Facts | Depression and Suicide
New FDA Warnings | Congressional Hearing | Submit a Case | Home

If you need immediate attention please call 1-800-942-2056

Accutane Suicide Help Line is a public advocacy group located at
One Boston Place, Suite 3615
Boston, MA 02108
Partners and Affiliates throughout the US
This site is not authorized by Roche Pharmaceuticals: the manufacturers of Accutane and is not an Official Site of Accutane

Use of this site is dictated by our terms and conditions